Encompass Health Corporation $EHC Shares Sold by Squarepoint Ops LLC

Squarepoint Ops LLC reduced its stake in Encompass Health Corporation (NYSE:EHC - Free Report) by 92.3% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 24,977 shares of the company's stock after selling 297,921 shares during the quarter. Squarepoint Ops LLC's holdings in Encompass Health were worth $2,525,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. California State Teachers Retirement System grew its holdings in shares of Encompass Health by 9,758.8% in the second quarter. California State Teachers Retirement System now owns 11,605,197 shares of the company's stock valued at $1,173,053,000 after purchasing an additional 11,487,483 shares during the period. BlackRock Inc. purchased a new position in Encompass Health during the second quarter worth about $1,059,762,000. Geode Capital Management LLC raised its stake in Encompass Health by 7.6% during the fourth quarter. Geode Capital Management LLC now owns 1,946,134 shares of the company's stock worth $206,605,000 after purchasing an additional 137,892 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Encompass Health by 3.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,674,784 shares of the company's stock valued at $162,013,000 after purchasing an additional 50,647 shares during the last quarter. Finally, Norges Bank purchased a new stake in shares of Encompass Health in the 4th quarter valued at approximately $133,221,000. Hedge funds and other institutional investors own 97.25% of the company's stock.

Encompass Health Trading Up 0.8%

Shares of EHC stock opened at $122.69 on Tuesday. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99. The firm has a market cap of $12.10 billion, a PE ratio of 19.98, a price-to-earnings-growth ratio of 2.46 and a beta of 0.75. The company has a 50-day moving average of $117.45 and a two-hundred day moving average of $108.17. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.19.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.48 by $0.07. The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The business's revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, analysts predict that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.7%. This is a positive change from Encompass Health's previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. Encompass Health's payout ratio is currently 13.68%.

Insider Buying and Selling at Encompass Health

In related news, EVP John Darby sold 8,906 shares of the stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the transaction, the executive vice president owned 75,041 shares of the company's stock, valued at approximately $9,451,413.95. This represents a 10.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Mark J. Tarr sold 173,148 shares of the firm's stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total value of $21,724,879.56. Following the transaction, the chief executive officer owned 267,814 shares of the company's stock, valued at $33,602,622.58. This trade represents a 39.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 186,912 shares of company stock valued at $23,434,845. Company insiders own 1.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on EHC. Truist Financial raised their price target on shares of Encompass Health from $140.00 to $150.00 and gave the stock a "buy" rating in a report on Friday, August 7th. Leerink Partners set a $152.00 price objective on Encompass Health in a report on Friday, May 22nd. Barclays increased their price objective on Encompass Health from $140.00 to $144.00 and gave the stock an "overweight" rating in a research report on Thursday, August 6th. UBS Group raised their target price on Encompass Health from $150.00 to $155.00 and gave the stock a "buy" rating in a research note on Friday, August 7th. Finally, Weiss Ratings raised Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, Encompass Health currently has a consensus rating of "Buy" and an average price target of $146.83.

Encompass Health Profile

Encompass Health Corporation NYSE: EHC is a provider of post-acute healthcare services in the United States. The company operates inpatient rehabilitation hospitals that care for patients recovering from illness, injury, surgery or other medical conditions requiring intensive rehabilitation.

Its rehabilitation programs commonly serve patients recovering from strokes, brain and spinal cord injuries, neurological disorders, cardiac and pulmonary conditions, hip fractures, amputations and other orthopedic conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.